Gams Gamora Cure

GET CURED IN HIV/AIDS, CANCER AMONG OTHERS. FOR DETAILS OR DIRECT TEXTS INTERACT WITH US VIA WHATSAPP

TODAYS TOPIC IS ON NUTRITION AND ITS IMPORTANCE

Nutrition
Nutrition is a critical part of health and development. Better nutrition is related to improved infant, child and maternal health, stronger immune systems, safer pregnancy and childbirth, lower risk of non-communicable diseases (such as diabetes and cardiovascular disease), and longevity.

Healthy children learn better. People with adequate nutrition are more productive and can create opportunities to gradually break the cycles of poverty and hunger.

Malnutrition, in every form, presents significant threats to human health. Today the world faces a double burden of malnutrition that includes both undernutrition and overweight, especially in low- and middle-income countries.

WHO is providing scientific advice and decision-making tools that can help countries take action to address all forms of malnutrition to support health and wellbeing for all, at all ages.

This fact file explores the risks posed by all forms of malnutrition, starting from the earliest stages of development, and the responses that the health system can give directly and through its influence on other sectors, particularly the food system.

A CURE FOR AIDS

Gammora is an artificial peptide compound Enzyme derived integrase, which is responsible for incorporating the genetic material of the virus into the DNA of the cell. Gammora excites the integration of various HIV DNA fragments into the host cell DNA, to a level that triggers the cell’s self-destruction, called apoptosis.
The medication appears to be a wide-spectrum fighter of viral replication (one is ribavirin, a medicine utilized in hepatitis C treatment). It can function to restrict viral propagation in established disease and the disease of additional cells.
These first outcomes were exceeding our expectations and assured confidence in finding a cure for a disease that’s been detected within 35 years, announced in a report Dr. Elvira Naftali, head of growth in Zion Medical. Given the limited nature of the analysis, we are eager to demonstrate our medication’s effectiveness in Stage 2b employing some participants within a more extended period.
In case this stage proves successful its consequences are life-altering. Now, present readily available HIV retroviral treatments that are work by controlling the expansion of the virus but don’t offer any remedy for the disease.
HIV sufferers may hope to get a better life span, not a real respite. The peptide of Zion Medical can destroy all cells bearing the HIV virus-genome offering an actual treatment for contaminated patients.
The medical stage 1/2a Gammora human trial of Zion Medical found that many patients revealed a significant reduction in the viral burden of about 90 percent in the research during the first four months.
In Part II of the investigation, Gammora was combined with additional retroviral remedies which led to patients demonstrating around 99 percent drop in viral load from baseline in four months.
Furthermore, during the process of tests, Gammora has been demonstrated to be well-tolerable and protected. In actual, no side effects have been reported.
What is more, Gammora was found to boost person CD4 cell Count 97 around percent from the baseline. CD4 cells, also known as T cells or some T cells are the cells that the HIV kills. They are white blood cells that play an integral role in the immune system, the natural protective measures against diseases, germs, and ailments of the body.
Since the increase of HIV infections, CD4 cells progress decrease. Someone is going to be diagnosed with AIDS if their numbers fall below 200 and will be viewed at high risk of contracting serious illnesses. For reference, a person range for CD4 cells is approx 500-1,500.
The news caused a frenzy entirely directing Zion Medical to describe the company has a long way in front of a remedy could be guaranteed, but it’s gotten a step nearer. The business also revealed their peer-reviewed research needs to be made available in 2019.
Zion Medical, the Israeli-based pharmaceutical company, recently revealed the news of a successful first clinical trial due to what they called a potential HIV remedy. They have issued a further statement on Twitter that makes it crystal clear that more experiments will be required, and their official results will need to get peer-reviewed and published.
Considering that the announcement was made by the company on October 31, there has been a tide of excitement on social websites together with individuals clamoring to find out more.
Zion Medical is a comparatively new company, based in 2014. According to the business website, it develops Cancer and AIDS-treating products based on peptides derived from HIV and targeted lentivirus particles.
Outcomes of the HIV drug’s first clinical trial, Gammora, have shown it can kill up to 99 percent of the virus within one month of treatment. The results declared confirm that Gammora significantly decreased the viral load in human cases by destroying the cells containing virus without harming healthy ones, unlike drugs that suppress the spreading of this virus.